Suppr超能文献

HES-1,芳烃受体的一个新的靶基因。

HES-1, a novel target gene for the aryl hydrocarbon receptor.

作者信息

Thomsen Jane Sohn, Kietz Silke, Ström Anders, Gustafsson Jan-Ake

机构信息

Department of Biosciences at NOVUM, Karolinska Institutet, Huddinge, Sweden.

出版信息

Mol Pharmacol. 2004 Jan;65(1):165-71. doi: 10.1124/mol.65.1.165.

Abstract

Known mainly for its role as a toxin sensor, the aryl hydrocarbon receptor (AhR) complex is also involved in homeostasis regulation and differentiation processes and activated by xenobiotic compounds like 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Hairy and Enhancer of Split homolog-1 (HES-1) is a key regulator not only in differentiation, but also in the cell cycle, and we show here that HES-1 is a new target gene for AhR regulation. HES-1 is up-regulated by TCDD both at protein and mRNA levels in T47D human mammary carcinoma cells. Actinomycin D experiments have shown that the AhR-mediated up-regulation of HES-1 mRNA is caused by transcriptional activation of the HES-1 gene, and we have identified a functional AhR response element (XRE) at -48/-42 in the upstream regulatory region of human HES-1. The HES-1 protein down-regulates expression of its own gene, and the HES element overlaps the XRE. Our data indicate that HES-1 and the AhR complex compete for binding to the composite HES/XRE element. Also, we have previously shown that HES-1 is down-regulated by the estrogen receptor ligand 17beta-estradiol (E2). Up-regulation of HES-1 expression is correlated with suppression of cell proliferation, and the E2-mediated down-regulation of HES-1 therefore increases cell proliferation. It is known that TCDD exerts antiestrogenic action in breast tissue both in vivo and in vitro. Our observation that both the estrogen receptor and AhR signaling pathways regulate HES-1, but with opposing effects, suggests the existence of a new pathway by which AhR represses E2-signaling.

摘要

芳烃受体(AhR)复合物主要因其作为毒素传感器的作用而闻名,它也参与体内稳态调节和分化过程,并被2,3,7,8-四氯二苯并对二恶英(TCDD)等外源性化合物激活。毛状分裂增强子同源物1(HES-1)不仅是分化的关键调节因子,也是细胞周期的关键调节因子,我们在此表明HES-1是AhR调节的一个新靶基因。在T47D人乳腺癌细胞中,TCDD在蛋白质和mRNA水平上均上调HES-1。放线菌素D实验表明,AhR介导的HES-1 mRNA上调是由HES-1基因的转录激活引起的,并且我们在人HES-1上游调控区-48/-42处鉴定出一个功能性AhR反应元件(XRE)。HES-1蛋白下调其自身基因的表达,并且HES元件与XRE重叠。我们的数据表明,HES-1和AhR复合物竞争结合复合HES/XRE元件。此外,我们之前已经表明HES-1被雌激素受体配体17β-雌二醇(E2)下调。HES-1表达的上调与细胞增殖的抑制相关,因此E2介导的HES-1下调增加细胞增殖。已知TCDD在体内和体外均在乳腺组织中发挥抗雌激素作用。我们观察到雌激素受体和AhR信号通路均调节HES-1,但作用相反,这表明存在一条新的途径,通过该途径AhR抑制E2信号传导。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验